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Dysfunction of protein quality control contributes
to the cellular pathology of polyglutamine (polyQ)
expansion diseases and other neurodegenerative
disorders associated with aggregate deposition.
Here we analyzed how polyQ aggregation interferes
with the clearance of misfolded proteins by the
ubiquitin-proteasome system (UPS). We show in a
yeast model that polyQ-expanded proteins inhibit
the UPS-mediated degradation of misfolded cyto-
solic carboxypeptidase Y* fused to green fluorescent
protein (GFP) (CG*) without blocking ubiquitylation or
proteasome function. Quantitative proteomic anal-
ysis reveals that the polyQ aggregates sequester
the low-abundant and essential Hsp40 chaperone
Sis1p. Overexpression of Sis1p restores CG* degra-
dation. Surprisingly, we find that Sis1p, and its
homolog DnaJB1 in mammalian cells, mediates the
delivery of misfolded proteins into the nucleus for
proteasomal degradation. Sis1p shuttles between
cytosol and nucleus, and its cellular level limits the
capacity of this quality control pathway. Upon
depletion of Sis1p by polyQ aggregation, misfolded
proteins are barred from entering the nucleus and
form cytoplasmic inclusions.INTRODUCTION
Cells maintain protein homeostasis (proteostasis) under a variety
of metabolic states and growth conditions. Molecular chaper-
ones and the protein degradation machinery cooperate within
a complex protein quality control network to prevent the accu-
mulation of potentially toxic misfolded proteins in the cytosol
and within subcellular compartments (Douglas and Dillin, 2010;
Hartl et al., 2011; Powers et al., 2009). Chaperones assist protein
folding, prevent aggregation, mediate the refolding of misfolded
proteins, and transfer terminally misfolded proteins to proteolytic134 Cell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc.degradation by the ubiquitin-proteasome system (UPS) or auto-
phagy (Rubinsztein, 2006). These mechanisms must be tightly
regulated to maintain proper proteome balance. Failure of pro-
teostasis control has been associated with the age-dependent
manifestation of a number of neurodegenerative aggregate-
deposition diseases, including Parkinson’s and Huntington’s
disease. Multiple lines of evidence suggest that ongoing protein
aggregation further compromises the proteostasis system,
aggravating cellular pathology (Douglas and Dillin, 2010; Gidale-
vitz et al., 2010).
Pathological protein aggregation concurrent with declining
proteostasis capacity has been documented extensively in
cellular and organismal models of polyglutamine (polyQ) expan-
sion diseases, such as Huntington’s disease and various forms
of ataxia. For example, expression of pathological polyQ pro-
teins in nematode and cellular models causes loss of function
of chaperone-dependent, metastable proteins (Gidalevitz et al.,
2006; Gupta et al., 2011). Moreover, polyQ expansion proteins
can impair normal UPS function by mechanisms that are not
yet well understood (Bence et al., 2001; Bennett et al., 2005;
Duennwald and Lindquist, 2008; Hipp et al., 2012a; Rousseau
et al., 2009; Venkatraman et al., 2004; Verhoef et al., 2002).
In the present studywe analyzed howexpandedpolyQproteins
interfere with the clearance of misfolded cytosolic proteins via the
UPS.Detailed investigationswereperformed in a yeastmodel and
key observations were then confirmed in human HEK293 cells.
UPS-mediated quality control was measured with cytosolic
carboxypeptidase Y* fused to green fluorescent protein (GFP)
(CG*) as a misfolded reporter protein (Heck et al., 2010; Park
et al., 2007; Prasad et al., 2010). Expression of polyQ-expanded
huntingtin exon 1 with 96Q or a C-terminal fragment of ataxin 3
with 71Q markedly inhibited the degradation of CG*. Quantitative
interactome analysis identified the essential but low-abundant
Hsp40 chaperone Sis1p as a strong interactor of soluble polyQ
aggregates and of insoluble polyQ inclusions. Surprisingly, we
discovered that Sis1p, and similarly its close human homolog
DnaJB1, has a specific role in transporting CG* and other mis-
folded proteins into the nucleus for proteasomal degradation. By
functionally depleting the rate-limiting Hsp40 chaperone, polyQ
aggregation disables this quality control pathway, thus augment-
ing protein misfolding and aggregate deposition in the cytosol.
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Figure 1. Impairment of Cytosolic Protein
Quality Control by PolyQ-Expanded Protein
(A) Schematic representation of the reporter pro-
tein CG* and of huntingtin exon 1 constructs 96Q
and 20Q. DssCPY* is a mutant version of the
secretory protein carboxypeptidase Y lacking the
signal sequence. Q, glutamine.
(B) Expression of 96Q and CG*. YPH499 cells
grown at 30C in SC medium containing 2%
glucose were shifted to 2% raffinose/2% galac-
tose to induce 96Q or 96Q/CG* expression for the
times indicated. CG* and 96Q were detected by
immunoblot analysis of cell lysates using anti-GFP
and anti-myc antibodies, respectively. Phospho-
glyerate kinase (PGK) was analyzed as loading
control using anti-PGK antibody.
(C) Turnover of CG* measured by cycloheximide
(CHX) chase. 96Q or 20Q was coexpressed with
CG* for 6 hr or 15 hr. CHX was added to inhibit
protein synthesis, cells were collected at the indi-
cated times and analyzed for CG* by anti-GFP
immunoblotting. CG* was quantified by densi-
tometry. Averages ± SD from four independent
experiments are shown.
(D) Formation of CG* inclusions upon coex-
pression with 96Q. Cells expressing 20Q-mCherry
(20QmCh) or 96QmCh together with CG* for 18 hr
at 30C were analyzed by live cell fluorescence
microscopy. Nuclei were counterstained with
Hoechst 33342. Scale bar, 10 mm.
(E) Growth of cells coexpressing 20Q or 96Q with
CG*. 6-fold serial dilutions of cells were spotted on
agar plates containing glucose ( induction) or
galactose (+ induction) to induce expression of
polyQ proteins and CG* and incubated for 4 days
at 30C. See also Figure S1.RESULTS
PolyQ Aggregation Inhibits Degradation of Misfolded
Cytosolic Proteins
We used yeast as a model organism to analyze the effect of
polyQ-expanded proteins on the clearance of misfolded cyto-
solic proteins. CG*, a mutant version of the secretory protein
carboxypeptidase Y lacking the signal sequence (DssCPY*)
and fused to GFP (Figure 1A), served as the reporter protein.
CG* is unable to fold in the reducing environment of the cytosol
and undergoes rapid UPS-mediated degradation in a manner
dependent on cytosolic Hsp70 (Ssa1p) and Hsp40 (Ydj1p)
(Park et al., 2007). Degradation occurs, at least in part, by nuclear
proteasome complexes (Heck et al., 2010; Prasad et al., 2010).
CG* was expressed under the PRC1 promoter, whereas normal
and pathological versions of huntingtin exon 1 with 20 gluta-
mines (20Q) and 96 glutamines (96Q), respectively, were
expressed under a galactose-inducible (GAL1) promoter (Kro-
bitsch and Lindquist, 2000; Meriin et al., 2002) (Figure 1A). These
experiments were performed under otherwise nonstress growth
conditions at 30C. After 9 hr of induction, SDS-insoluble 96Q
aggregates were detectable by SDS-PAGE or filter-trap assay
of cell extracts (Figures 1B and S1A available online). Somewhat
larger amounts of SDS-insoluble 96Q accumulated when 96Q
and CG* were coexpressed (Figure S1A). The turnover of CG*was assessed by inhibition of protein synthesis with cyclohexi-
mide (CHX). Rapid degradation of CG* was observed after 6 hr
of 96Q expression (Figure 1C). However, after 15 hr of 96Q
expression, degradation of CG* was strongly inhibited, whereas
rapid turnover was preservedwith expression of 20Q (Figure 1C).
CG* degradation was also impaired upon expression of an unre-
lated polyQ protein, AT3c71Q, an aggregating C-terminal frag-
ment of ataxin 3 with 71Q (Figure S1B) (Haacke et al., 2006).
This indicates that inhibition of protein clearance does not
depend on the specific sequence context of the polyQ segment.
To examine whether the inhibition of degradation was due
to coaggregation of CG* with 96Q, we expressed 96Q as a
C-terminal fusion with mCherry fluorescent protein (96QmCh).
CG* was also under control of theGAL1 promoter in these exper-
iments, which results in higher expression levels than the PRC1
promoter. 96QmCh preserved the ability to inhibit CG* degrada-
tion and cytoplasmic CG* inclusions were generally observed
(Figure 1D). However, the CG* inclusions did not overlap with
the inclusions formed by 96QmCh (Figure 1D) and no SDS-
resistant CG* protein was detected (Figure S1A). Similar obser-
vations were made upon expression of AT3c71Q (Figure S1C).
Neither the expression of 96Q nor of CG* alone resulted in an
overt growth defect in yeast cells (Behrends et al., 2006;
Krobitsch and Lindquist, 2000). However, when combined with
96Q, low levels of CG* expressed from the PRC1 promoterCell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc. 135
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Figure 2. Proteasome Function and Ubiqui-
tylation Are Not Affected by 96Q
(A) Possible mechanisms of inhibition of CG*
degradation by 96Q. CG* is stabilized by molec-
ular chaperones (MC), followed by ubiquitylation
mediated by E2 and E3 enzymes prior to protea-
somal degradation.
(B) Inhibition of CG* degradation occurs upstream
of the proteasome. CG* and GFPcODC were
coexpressed with either 96QmCh or 20QmCh.
After 18 hr of induction, CHX was added to follow
the decay of CG* and GFPcODC as in Figure 1C,
using PGK as loading control.
(C) Targeting 96Q to the proteasome relieves the
block of CG* degradation. CG* was coexpressed
with 96QcODC or 20QcODC for 15 hr at 30C.
96QcODC* or 20QcODC* containing a muta-
tionally disabled cODC degron were expressed as
controls (lower). The turnover of CG* was analyzed
after addition of CHX and CG* was quantified.
Averages ± SD from at least four independent
experiments are shown. The p value (Student’s
t test) for the difference in fractional CG*
degradation at 90 min between 96QcODC and
96QcODC* is indicated.
(D) 96QmCh does not interfere with CG* ubiq-
uitylation. His6-Ub conjugated proteins were
isolated from cells expressing 20QmCh or
96QmCh, CG*, or vector controls and His6-Ub in
the combinations indicated, followed by 4%–12%
gradient SDS-PAGE and immunoblotting with
anti-CPY antibody to detect ubiquitylated CG*.
CPY marks the position of endogenous CPY
protein. See Figure S2.were sufficient to cause a substantial growth retardation (Fig-
ure 1E), suggesting a breakdown of proteostasis control.
96Q Inhibits CG* Degradation without Blocking
Ubiquitylation or Proteasome Function
How do polyQ expansion proteins inhibit the degradation of
misfolded cytosolic proteins via the UPS? The interference
with protein clearance might occur upstream of the proteasome,
at the level of accessory chaperone factors and/or ubiquitylation
(Figure 2A). Alternatively, aggregating polyQ might block the
proteolytic chamber of the 20S proteasome and/or inhibit the
function of the 19S regulatory particle (Figure 2A). These possi-
bilities are not mutually exclusive.
First, we tested whether the proteasome is inhibited by 96Q.
To this end we used GFP tagged at the C terminus with the 37
amino acid degron of ornithine decarboxylase (cODC), which
targets the protein to the 26S proteasome in a ubiquitin-
independent manner (Zhang et al., 2003). Coexpression of
96QmCh did not interfere with the rapid turnover of GFPcODC,
even though CG* degradation was inhibited (Figure 2B).
Moreover, when cODC was fused to the C terminus of 96Q
(96QcODC), the resulting fusion protein was effectively
degraded (Figure S2A), and the block of CG* degradation was
partially relieved (Figure 2C). In contrast, 96Q carrying the
mutated cODC(C441A) degron (96QcODC*) (Zhang et al.,
2003) was stabilized (Figure S2A) and interfered with CG* degra-
dation (Figure 2C). These results exclude direct proteasome136 Cell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc.inhibition by 96Q as the cause of CG* stabilization in our exper-
imental system.
Next, we tested whether CG* was efficiently ubiquitylated in
the presence of 96Q. These experiments were performed in cells
expressing His6-ubiquitin (His6-Ub). Inhibition of CG* degrada-
tion by 96Q was preserved (Figure S2B) and ubiquitylated
proteins were isolated from cell extracts by talon magnetic
beads under denaturing conditions (see Figure S2C for input
fractions). When CG* was expressed either alone or together
with 20QmCh or 96QmCh, ubiquitylated CG* was detected in
pull-downs by immunoblotting with anti-CPY antibody (Fig-
ure 2D, lanes 5–7). Coexpression with 96QmCh did not reduce
the amount of ubiquitylated CG* (Figure 2D, lane 7). To test
whether ubiquitylation of CG* was limiting for degradation, we
overexpressed the E3 ubiquitin ligase Ubr1p, which is involved
in the ‘‘N end rule’’ degradation pathway and is also required
for efficient CG* degradation (Eisele and Wolf, 2008; Heck
et al., 2010; Varshavsky, 2012). Ubr1p overexpression did not
rescue CG* degradation in the presence of 96QmCh, but stimu-
lated degradation in 20QmCh expressing cells (Figure S2D). In
summary, 96Q does not interfere directly with the function of
the proteasome or inhibit CG* ubiquitylation.
Identification of 96Q Interactors
The results described above suggested that 96Q inhibits CG*
degradation by sequestering one or more factors required
upstream of the proteasome, in addition to ubiquitylation.
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Figure 3. Identification of Sis1p as a
Functionally Critical 96Q Interactor
(A) Fold enrichment of interactors on 96QmCh
relative to 20QmCh determined by quantitative
proteomics using SILAC (Table S1). Molecular
chaperones (red) and UPS components (blue)
are shown.
(B) Interaction of Sis1p with 96Q inclusions
demonstrated by fluorescence complementation.
YPK011 cells in which SIS1 was replaced by
a construct encoding Sis1p fused with the
N-terminal half of Venus fluorescence protein
(Sis1-VN) were transformed with 20Q or 96Q fused
with the C-terminal half of Venus (96Q-VC and
20Q-VC, respectively). Transformation with empty
vector served as control. After 15 hr of polyQ
expression, Venus fluorescence was observed by
live cell fluorescence microscopy. Scale bar,
10 mm.
(C) Overexpression of Sis1p restores CG*
degradation in the presence of 96QmCh. A
plasmid encoding Sis1p under control of TDH3 or
empty vector was introduced into cells coex-
pressing 96QmCh and CG*. The turnover of CG*
was analyzed after addition of CHX and CG* was
quantified. Anti-Sis1p, anti-GFP and anti-PGK
antibodies were used for immunoblotting,
respectively. Averages ±SD from three indepen-
dent experiments are shown.
(D and E) Cells coexpressing 96QmCh and CG*,
overexpressing Sis1p as above (D) or over-
expressing Ydj1p or Ssa1p (E) as in Figures S3E
and S3F but without CHX treatment were analyzed
by live cell fluorescence and DIC microscopy.
Scale bars, 10 mm. See also Table S1 and
Figure S3.To identify proteins that preferentially interact with 96Q relative
to 20Q, we performed a quantitative interactome analysis using
SILAC (stable isotope labeling with amino acids in cell culture)
(Ong and Mann, 2006). Cells expressing 96QmCh and CG*
were labeled for 20 hr with heavy lysine isotope, while
20QmCh andCG* expressing cells grown in light medium served
as control. 96QmCh and 20QmCh were isolated with anti-myc
antibodies (Figure 1A) from cell extracts that had been clarified
by centrifugation to remove polyQ inclusions. The isolated frac-
tions were mixed 1:1, separated by SDS-PAGE, followed by
in-gel digestion and LC-MS/MS analysis. Approximately 100
proteins were found to be enriched >2-fold (up to 100-fold) in
pull-downs of 96QmCh over 20QmCh in at least two of three
independent experiments (Table S1). Among the highly enriched
interactors are several Q-rich proteins (Pub1, Sgt2, and Def1)
and known yeast prion proteins (Rnq1, Sup35, Cyc8, and Pin3)
(Table S1). Q-rich proteins tend to coaggregate with pathological
polyQ proteins (Schaffar et al., 2004). The association of 96Q
with the Q/N-rich prion proteins likely reflects the requirement
of the prion status for the seeding of polyQ aggregation in yeast
(Meriin et al., 2002).
Two groups of 96Q interactors were of particular interest in the
functional context of protein degradation, molecular chaperones
(and cochaperones) and components of the UPS (Figure 3A).
The latter included the highly enriched protein Dsk2 and severalmoderately enriched subunits of the 19S proteasome complex.
Dsk2 contains ubiquitin-like (UBL) and ubiquitin-associated
(UBA) domains and is involved in the delivery of polyubiquity-
lated proteins to the proteasome. However, Dsk2 is dispensable
for CG* degradation (Medicherla et al., 2004), and we found that
Dsk2 deletion even accelerated CG* turnover (data not shown),
ruling out functional depletion of Dsk2 by 96Q as the cause of
CG* stabilization.
The chaperone proteins associated with 96Q included several
factors of the Hsp70 system, with the type II Hsp40, Sis1p, being
30-fold enriched on 96Q over 20Q (Figure 3A). Sis1p, a homo-
dimer of 38 kDa subunits, is an essential but low-abundant
cochaperone of the Ssa class of Hsp70s (Yan and Craig,
1999). It appears to be functionally unique compared to other
Hsp40s (Kampinga and Craig, 2010; Yan and Craig, 1999) and
is critical for yeast prion propagation (Sondheimer et al., 2001;
Summers et al., 2009). The association of Sis1p with insoluble
96Q inclusions was analyzed by fluorescence complementation.
The SIS1 gene was replaced by a construct encoding Sis1p
fused to the N-terminal half of Venus fluorescent protein (Sis1-
VN). 20Q and 96Qwere expressed as fusions with the C-terminal
half of Venus (20Q-VC, 96Q-VC). A strong association of Sis1-VN
with inclusions of 96Q-VC was observed by Venus fluorescence
(Figure 3B). Indeed, upon cell fractionation, 50% of endoge-
nous Sis1p was recovered in the pellet fraction of lysates fromCell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc. 137
96Q expressing cells, compared to only 8% in 20Q expressing
cells (Figure S3A). Moreover,50% of soluble Sis1p was specif-
ically associated with soluble 96Q species (Figure S3B), which
included oligomeric complexes fractionating at 400–700 kDa
(data not shown). Similarly, a large fraction of Sis1p was
insoluble upon expression of AT3c71Q and soluble species
of AT3c71Q were also associated with Sis1p (Figures S3C
and S3D).
Sis1p Is Rate Limiting for CG* Degradation
Molecular chaperones recognize and stabilize terminally mis-
folded proteins for degradation (Hartl et al., 2011). We therefore
tested whether Sis1p sequestration by 96Q caused the inhibition
of CG* degradation. In support of this possibility, overexpression
of Sis1p fully restored the degradation of CG* (Figure 3C) and
markedly suppressed the formation of 96QmCh inclusions (Fig-
ure 3D). Notably, Sis1p overexpression does not cure yeast cells
of the [RNQ1+] prion (Hines et al., 2011) and thus does not sup-
press polyQ aggregation by reversing the prion state. Surpris-
ingly, overexpression of the abundant type I Hsp40, Ydj1p; the
constitutive Hsp70, Ssa1p; or the small heat shock protein,
Hsp42p, failed to restore CG* degradation (Figures S3E and
S3F and data not shown). This was the case even though the
solubility of both CG* and 96Q was improved (Figures 3E and
S3G) and CG* was diffusely distributed in the cytosol upon over-
expression of Ydj1p (Figure 3E). Furthermore, overexpression of
Ydj1p or Ssa1p tended to retard CG* degradation even in control
cells expressing 20Q (Figures S3E and S3F). Sis1p overexpres-
sion fully rescued the growth defect of cells coexpressing 96Q
and CG* (Figure S3H). These findings pointed to a specialized
role of Sis1p in maintaining proteostasis by mediating the degra-
dation of misfolded proteins.
To determine whether Sis1p is normally involved in the
clearance of misfolded proteins, we depleted Sis1p in yeast cells
(not expressing polyQ protein), in which the SIS1 promoter was
replaced by a tetracycline-regulated promoter (Tet-Off).
Replacing the promoter reduced Sis1p levels by about 25%
compared to wild-type (Figure 4A, top left). Notably, this
moderate reduction was already sufficient to strongly retard
the degradation of CG* (Figure 4A, bottom left), to an extent
comparable to the inhibition observed upon 96Q expression
(Figures 1C and 3C). Addition of doxycycline (DOX), resulting in
85% Sis1p depletion within 20 hr (Figure 4A, top right), had
only a mild additional effect on CG* degradation (Figure 4A,
bottom right). The inhibition of CG* degradation upon Sis1p
depletion was not due to loss of CG* ubiquitylation, as deter-
mined by immunoprecipitation of CG* followed by antiubiquitin
immunoblotting (Figure S4A; see also Figures 2D and S2C). In
conclusion, the data indicate that Sis1p is rate limiting for CG*
turnover, likely at a postubiquitylation step. Sequestration of
Sis1p by polyQ aggregates is therefore sufficient to explain the
stabilization of CG* in 96Q expressing cells.
Sis1p Cooperates with Hsp70 in the Degradation
of Misfolded Proteins
Does Sis1p cooperate with cytosolic Hsp70s in CG* degra-
dation? Functional cooperation between Hsp40s and Hsp70
depends on the His-Pro-Asp (HPD)-loop segment in the138 Cell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc.Hsp40 J domain (Kampinga and Craig, 2010). We mutated the
HPD-loop residues of Sis1p to alanine (Sis1AAA) or deleted
residues 1–76 comprising the entire J domain (Sis1DJ). The
mutant proteins were expressed in cells depleted of endogenous
Sis1p to test whether they could support CG* degradation. In
contrast to Sis1p, Sis1AAA did not mediate rapid degradation
of CG*, which formed inclusions in the cytoplasm (Figure 4B
and data not shown). These results indicate that Sis1p func-
tionally cooperates with Hsp70 in CG* degradation. To confirm
the physical interaction, we immunoprecipitated Sis1p, Sis1DJ,
or Sis1AAA with antibodies against their N-terminal HA-tag,
followed by immunoblot analysis (Figure 4C). All Sis1p proteins
tested formed ternary complexes with Ssa1p and CG*, with
increased amounts of CG* being recovered with Sis1DJ and
Sis1AAA. The amount of Ssa1p in the complexes was reduced
for Sis1DJ. These findings are consistent with Sis1p binding to
CG* and recruiting the Hsp70 via the Sis1p J domain, perhaps
allowing a more stable interaction of Hsp70 with ubiquitylated
substrate than in the presence of Ydj1p.
To test whether Sis1p is generally required for the degradation
of cytosolic proteins, we analyzed the catabolite-regulated
degradation of fructose-1,6-bisphosphatase (FBPase), a key
enzyme in gluconeogenesis. FBPase is expressed when cells
are grown in nonfermentable carbon sources but is rapidly
degraded via the UPS upon addition of glucose (Juretschke
et al., 2010). FBPase was degraded with equivalent kinetics in
wild-type and Sis1p-depleted cells (Figure 4D). Likewise, Sis1p
was not required for the degradation of the short-lived protein
UbG76V-GFP (Figure S4B). In conclusion, Sis1p appears to be
specifically required for the degradation of misfolded cytosolic
proteins and cooperates in this function with Hsp70.
Sis1p is Required for Delivery of CG* to the Nucleus
for Degradation
One strategy of cytosolic quality control in yeast is to transfer
misfolded proteins for degradation into the nucleus, which con-
tains 70%–80%of cellular proteasome complexes (Russell et al.,
1999). This pathway also contributes to the clearance of CG*
(Heck et al., 2010; Prasad et al., 2010), but how misfolded pro-
teins are recognized in the cytosol and imported into the nucleus
has remained unclear. Accordingly, we tested the possible
involvement of Sis1p in this process. Interestingly, CG* accumu-
lated in large cytoplasmic inclusions when Sis1p was strongly
(85%) or moderately (25%) depleted (Figures 5A and S5A),
consistent with a role of Sis1p in delivering CG* to the nucleus.
Indeed, we confirmed that degradation of CG* occurs predomi-
nantly, if not exclusively, in the nucleus: targeting CG* to the
nucleus by a nuclear localization signal (NLS-CG*) substantially
accelerated its degradation (Figure 5B), whereas attachment of
a nuclear export signal (NES-CG*) dramatically stabilized the
protein (Figure 5B).
Next, we analyzed the subcellular location of CG* and Sis1p
upon inhibition of proteasome function with MG132. These
experiments were performed in Dpdr5 cells lacking the ABC
transporter Pdr5 and allowing the intracellular accumulation of
the inhibitor. Fluorescence imaging of MG132-treated cells
demonstrated the presence of CG* in juxtanuclear, cytoplasmic
inclusions (Figure 5C). In addition, a fraction of CG* was diffusely
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Figure 4. Essential Role of Sis1p in CG*
Degradation
(A) Moderate depletion of Sis1p results in CG*
stabilization. CG* was expressed in wild-type cells
(R1158) and in Tet-Off SIS1 cells. Cells were grown
for 20 hr either without (DOX) or with 10 mg/ml
doxycycline (+DOX) and CG* turnover was
analyzed. Note that Tet-Off SIS1 cells grown
without DOX are 25% depleted of Sis1p
compared to wild-type cells (R1158). Immunoblots
developed with anti-Sis1p and anti-CPY anti-
bodies are shown and the amounts of Sis1p and
CG* were quantified. Averages of at least three
independent experiments and p values for the
difference in fractional CG* degradation for the
120 min time points are indicated. A band cross-
reacting with anti-Sis1p (indicated by *) and
endogenous CPY served as loading controls.
(B) Sis1p with mutated J domain (Sis1AAA) cannot
replace wild-type Sis1p for CG* degradation.
Plasmids encoding N terminally HA-tagged Sis1p
or Sis1AAA under control of GAL1 promoter were
introduced into Tet-Off SIS1 cells expressing CG*
and grown for 20 hr with DOX to deplete endoge-
nous Sis1p as in (A). CG* turnover was analyzed
after addition of CHX. CG*, Sis1p, Sis1AAA, and
PGK were detected by immunoblotting. CG* was
quantified and averages ± SD from three inde-
pendent experiments are shown.
(C) Sis1p forms complexes with Ssa1p and CG*.
Tet-Off SIS1 cells expressing Sis1p, Sis1DJ (Sis1p
lacking the entire J domain), Sis1AAA as well as
CG* were grown with DOX as in (A). Anti-HA im-
munoprecipitations were analyzed by immuno-
blotting with anti-HA, anti-Ssa1p, and anti-GFP
antibodies, respectively.
(D) Catabolite induced degradation of fructose-
1,6-bisphosphatase (FBPase) is Sis1p indepen-
dent. Wild-type and Tet-Off SIS1 cells were grown
for 20 hr in media containing 2% ethanol and DOX.
Degradation of FBPase was initiated by trans-
ferring the cells to medium containing 2% glucose
and DOX. FBPase, Sis1p, and PGK were analyzed
by immunoblotting. See also Figure S4.distributed in the nucleus. Interestingly, Sis1p almost exclusively
localized to the nucleus upon proteasome inhibition (Figure 5C),
suggesting that its depletion from the cytoplasm triggered the
deposition of CG* in inclusions. Similar observations were
made in cells lacking the nuclear E3 ligase San1p (Gardner
et al., 2005), which acts in parallel with Ubr1 in CG* degradation
(Heck et al., 2010). Again CG* accumulated in juxtanuclear inclu-
sions and in the nucleus (Figure 5D). Relocation of Sis1p to the
nucleus was clearly detectable but less pronounced than upon
MG132 treatment, consistent with only partial inhibition of CG*
degradation in Dsan1 cells (Heck et al., 2010). Notably, some
accumulation of Sis1p in the nucleus was also observed upon
proteasome inhibition in cells not expressing CG* (Figure S5B),
presumably reflecting a general role of Sis1p in the nuclear
degradation of misfolded cytosolic proteins.
Having established that Sis1p has a role in delivering the
terminally misfolded CG* into the nucleus, we asked whether
inhibition of Sis1p shuttling between the cytoplasm and the nu-
cleus interferes with CG* degradation. We constructed versionsof Sis1p with a N-terminal nuclear export signal (NES-Sis1p) or
nuclear import signal (NLS-Sis1p) and expressed them in cells
depleted of endogenous Sis1p. NLS-Sis1p was efficiently tar-
geted to the nucleus, whereas NES-Sis1p was diffusely distrib-
uted in the cytoplasm (Figure 5E). Neither protein was able to
restore CG* degradation and cytoplasmic CG* inclusions formed
in both cases. Notably, NES-Sis1p also afforded substantial CG*
stabilization in wild-type cells containing normal levels of Sis1p
(Figure S5C), perhaps through formation of mixed dimers with
wild-type Sis1p. This dominant inhibitory effect suggests that
NES-Sis1p engages CG* but mediates its export from the
nucleusbefore transfer to thenuclearUPSmachinery is achieved.
Sis1p has no nuclear targeting sequence but was reported to
accumulate in the nucleus upon heat stress in a manner depen-
dent on the essential importin-a, Srp1 (Malinovska et al., 2012).
Indeed, CG* was partially stabilized in cells hypomorphic for
SRP1 compared to the corresponding wild-type strain (Fig-
ure S5D) (Breslow et al., 2008), consistent with a direct or indirect
role of Srp1p in the pathway of nuclear CG* degradation.Cell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc. 139
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Figure 5. Sis1p is Required for Transfer of CG* Into the Nucleus for Degradation
(A) Depletion of Sis1p results in the formation of cytoplasmic CG* inclusions. Tet-Off SIS1 cells expressing CG* were transformed with SIS1 as in Figure 4B and
grown in the presence of DOX for 20 hr to deplete endogenous Sis1p. Live cells were analyzed by DIC and fluorescence microscopy. Nuclei were counterstained
with Hoechst 33342. Scale bar, 10 mm.
(B) Nuclear degradation of CG*. Degradation of CG* was analyzed upon addition of CHX in wild-type cells expressing NLS-CG*, CG*, or NES-CG* under GAL1
promoter. CG* proteins were detected with anti-GFP antibody and quantified by densitometry. Averages of three independent experiments and p values for the
difference in fractional CG* degradation at the 3 hr time points are indicated. PGK was used as loading control.
(C) CG* and Sis1p accumulate in the nucleus upon proteasome inhibition. CG* was expressed in Dpdr5 cells for 18 hr, followed by addition of 1% DMSO or
100 mMMG132 in DMSO for 2 hr. Sis1pwas immunolabeledwith rabbit anti-Sis1p antibody coupled toCy3-conjugated goat anti-rabbit antibody andCG* byGFP
fluorescence. Nuclei were counterstained with DAPI. Scale bar, 10 mm.
(D) CG* and Sis1p accumulate in the nucleus in Dsan1 cells. CG* was expressed in wild-type (WT) and Dsan1 cells for 18 hr and analyzed as in (C).
Scale bar, 10 mm.
(E) Cytoplasmic-nuclear shuttling of Sis1p is required for CG* degradation. Plasmids encoding Sis1p, NLS-Sis1p or NES-Sis1p (all N terminally HA-tagged) were
introduced into Tet-Off SIS1 cells expressing CG*. Endogenous Sis1p was depleted by addition of DOX. Sis1 proteins expressed under theGAL1 promoter were
immunolabeled with mouse anti-HA antibody coupled to Cy3-conjugated goat anti-mouse antibody and CG* by GFP fluorescence. Nuclei were stained with
DAPI. Scale bar, 10 mm. See also Figure S5.In summary, Sis1p is an essential element of a quality control
pathway that mediates the removal of cytosolic misfolded pro-
teins to the nucleus for proteasomal degradation. When the pro-
duction of misfolded substrates exceeds the transport capacity
of Sis1p, these proteins are deposited in cytosolic inclusions.
Role of Sis1p Homolog in Protein Degradation in
Mammalian Cells
To test whether the key observations from the yeast model can
be reproduced in mammalian cells, we generated HEK293 cells
stably expressing DssCPY*-mCherry (CmCh*). CmCh* was
mainly localized in the cytosol (Figure S6A). Addition of CHX140 Cell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc.resulted in its rapid degradation with a half-time of 2 hr (Fig-
ure S6B). Proteasome inhibition caused the accumulation of
CmCh* concomitant with the formation of nuclear and juxtanu-
clear inclusions (Figures S6A and S6C), indicating that in
mammalian cells, as in yeast, a misfolded protein that is normally
localized in the cytosol is degraded in the nucleus. Downregula-
tion of DnaJB1, one of several human homologs of Sis1p, by
siRNA slowed the turnover of CmCh* (t1/2 4.5 hr) (Figure S6B),
suggesting that the chaperone is involved in nuclear protein
degradation. Next, we analyzed the effect of polyQ proteins on
CmCh* clearance by transiently transfecting CmCh* cells with
97Q or 25Q fused to GFP (97QG and 25QG, respectively).
CmCh* strongly accumulated when cells expressed 97QG
above a threshold level, as detected by FACS analysis (Fig-
ure S6D). This was not observed in cells expressing equivalent
amounts of 25QG (Figure S6D), indicating that the accumulation
of CmCh* was due to inhibition of degradation by 97QG. Overex-
pression of DnaJB1 suppressed this inhibitory effect (Fig-
ure S6D), similar to the observations with Sis1p in yeast cells
(Figure 3C).
To investigate whether DnaJB1 has a more general role in the
nuclear degradation of misfolded cytosolic proteins, we
analyzed the turnover of a conformationally destabilized mutant
of firefly luciferase fused to GFP (LG*) (Gupta et al., 2011). LG*
was degraded in HEK293 cells with a half-time of 3.5 hr (Fig-
ure S6E). The protein was diffusely distributed in the cytoplasm
but accumulated in nuclear and cytoplasmic inclusions upon
proteasome inhibition (Figure 6A). Notably, NES-LG*, the cyto-
solic version of LG*, was stabilized (t1/2 6 hr) relative to LG*,
whereas degradation was accelerated for NLS-LG* (t1/2 2 hr)
(Figure S6E). NES-LG* nevertheless formed nuclear inclusions
upon proteasome inhibition (Figure 6A), suggesting that it was
also degraded in the nucleus. Indeed, addition of leptomycin
B, a small molecule inhibitor of the nuclear exportin Crm1
(Kudo et al., 1999), significantly accelerated the degradation of
NES-LG* (t1/2 3 hr) (Figure 6B). Notably, downregulation of
DnaJB1 delayed degradation (Figure 6C) and resulted in the
formation of juxtanuclear NES-LG* inclusions (Figure 6D).
Moreover, whereas proteasome inhibition in control cells
caused the formation of nuclear NES-LG* inclusions, predomi-
nantly large cytoplasmic aggregates of NES-LG* accumulated
upon downregulation of DnaJB1 in combination with protea-
some inhibition (Figure 6D). This indicates that DnaJB1 is
necessary for efficient uptake of the misfolded protein into the
nucleus. Together, these results suggest that the role of Sis1p
in the nuclear degradation of misfolded, cytosolic proteins is
conserved in mammalian cells.
DISCUSSION
Herewe established a yeastmodel to investigate themechanism
by which polyQ aggregation interferes with cellular protein
quality control. We showed that polyQ aggregates interact with
and functionally deplete the low-abundant Hsp40 chaperone
Sis1p, thereby inhibiting the degradation of misfolded proteins
via the UPS. This effect is explained by our finding that Sis1p
is specifically required for the transfer of cytosolic misfolded
proteins to the nucleus for degradation (Figure 7), a function
which is conserved in mammalian cells. These results demon-
strate that the proteostasis network is highly vulnerable to
pathologic protein aggregates, due to their capacity to sequester
critical proteostasis regulators.
Sequestration of Sis1p by PolyQ Aggregates
Using the terminally misfolded protein CG* as a reporter, we
showed that polyQ proteins inhibit the degradation of this
cytosolic misfolded protein by depleting the low-abundant but
essential Hsp70 regulator Sis1p. The effect of Sis1p on CG*
degradation is specific, as overexpression of Ssa1p or Ydj1p
fails to restore CG* clearance in 96Q expressing cells. Althoughthese abundant chaperones contribute to CG* degradation (Park
et al., 2007), they are not limiting under the conditions of polyQ
expression analyzed here. We find that 50% of total Sis1p is
associated with insoluble 96Q inclusions. Additionally, 50%
of the remaining soluble Sis1p is associated with soluble 96Q
species. Importantly, a 25% reduction in the total Sis1p was
sufficient to slow the turnover of CG*, independent of 96Q
expression (Figure 4). Thus, sequestration of Sis1p by the polyQ
aggregates explains the observed inhibition of CG* degradation,
although aberrant interactions of the aggregates with other
factors may also contribute. For example, we identified several
components of the nuclear pore complex as 96Q interactors
(Table S1), which may add to the observed defect in nuclear
uptake of misfolded proteins.
The present study describes mechanisms that may contribute
generally to cellular polyQ toxicity. Indeed, Hsp40 proteins have
been observed in mammalian cell models in association with the
aggregates of different polyQ proteins (Hageman et al., 2010).
Specifically, the close homolog of Sis1p, DnaJB1, was found in
polyQ inclusions of postmortem brain tissue from spinocere-
bellar ataxia type 3 (SCA3) patients (Chai et al., 1999), consistent
with our finding that Sis1p associates with aggregates of a
C-terminal fragment of ataxin 3 in the yeast model. A recent
quantitative analysis of aggregation profiles in SCA3 brains
showed that in a subset of pontine neurons,DnaJB1was seques-
tered into nuclear inclusions of ataxin 3 and depleted from the
cytosol (Seidel et al., 2012). Moreover, DnaJB protein levels in
patient fibroblasts were found to correlate inversely with the
age of onset and the severity of SCA3 (Zijlstra et al., 2010).
Role of Sis1p in Nuclear Degradation of Cytosolic
Misfolded Proteins
The nuclear degradation of misfolded cytosolic proteins in yeast
has previously been reported (Heck et al., 2010; Prasad et al.,
2010), but how these proteins are specifically sorted to the
nucleus had remained unclear. Our study identified Sis1p as a
critical component in this process. Indeed, in addition to the
reporter protein used here, Sis1p is also required for the degra-
dation of terminally misfolded mutant GFP, as reported recently
(Summers et al., 2013). Similar to CG*, this protein was found to
be rapidly degraded in a Ubr1-dependent manner, but it formed
cytoplasmic inclusions at low Sis1p levels. In light of our findings,
it is likely that Sis1p functions in transferring themutant GFP pro-
tein to the nucleus for degradation. Whether misfolded cytosolic
proteins are generally degraded in the nucleus remains to be
determined, but it seems plausible that the Sis1p independent,
regulatory degradation of proteins like FBPase is performed by
cytosolic proteasome complexes. In any case, the accumulation
of misfolded protein species upon Sis1p depletion may well
explain why cells cannot tolerate the loss of Sis1p, although
other roles in proteostasis may contribute to the essential nature
of this chaperone.
Sis1p cooperates in protein degradation with Ssa class
Hsp70s, presumably by binding to preformed Ssa/Ydj1p/
substrate complexes or by replacing Ydj1p in such complexes
(Figure 7). As ubiquitylation of CG* was not impaired by Sis1p
depletion, recruitment of Sis1p may occur before or after ubiqui-
tylation. It is possible that Sis1p has a high affinity for misfolded,Cell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc. 141
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Figure 6. Conserved Function of Sis1p Homolog in Mammalian Cells
(A) Nuclear accumulation of mutant luciferase fused to GFP (LG*) upon proteasome inhibition. HEK293 cells stably expressing LG* or NES-LG* were treated with
5 mM MG132 or 0.1% DMSO control for 8 hr before analysis by confocal fluorescence microscopy. Nuclei were stained with DAPI. Representative confocal
micrographs are shown. Scale bars, 10 mm.
(B) Degradation of NES-LG* is accelerated by inhibition of nuclear export. NES-LG* cells were treated with 10 ng/ml of leptomycin B or ethanol control and
degradation of NES-LG* assessed upon addition of CHX (140 mg/ml). NES-LG* was detected by immunoblotting with anti-GFP antibody and quantified by
densitometry. Averages ± SD from six independent experiments and the p value for the difference in fractional NES-LG* degradation at the 9 hr time point are
shown.
(C) Downregulation of DnaJB1 retards degradation of NES-LG*. Degradation of NES-LG* was analyzed as in (B) in cells transfected either with control siRNA or
DnaJB1 siRNA (Figure S6 and Extended Experimental Procedures). Averages ± SD from three independent experiments with downregulation of DnaJB1
being >75% are shown. p value is indicated as in (B).
(D) DnaJB1 is required for shuttling of LG* into the nucleus for degradation. NES-LG* was stably expressed in cells transfected either with control siRNA or
DnaJB1 siRNA and treated either with MG132 or DMSO for 8 hr as in (A). NES-LG* was visualized by GFP fluorescence and nuclei were stained with DAPI. Scale
bars, 10 mm. See also Figure S6.ubiquitylated proteins and thus may effectively stabilize their
interaction with Hsp70 (Figure 7). In any case, association with
Sis1p will shift the fate of bound client protein from (attempted)142 Cell 154, 134–145, July 3, 2013 ª2013 Elsevier Inc.refolding to degradation, based on the ability of Sis1p, but not
Ydj1p, to mediate import into the nucleus where the majority of
cellular proteasome complexes reside. The low abundance of
Figure 7. Model of the Role of Sis1p in Nuclear
Degradation of Misfolded Cytosolic Proteins
Misfolded proteins such as CG* (green) are initially
stabilized in a soluble state by Hsp70s of the Ssa
class, probably in cooperation with the abundant
Hsp40, Ydj1. Attempted refolding through protein
binding and release, and eventually ubiquitylation by
Ubr1 (presumably by CHIP in mammalian cells) may
occur. Recognition of misfolded protein by Sis1p
dimer leads to remodeling of the initial chaperone
complex, shifting from refolding to degradationmode.
Sis1p stabilizes the association with Hsp70 and
mediates protein import into the nucleus for protea-
somal degradation. The nuclear E3 ligase San1,
acting in parallel to cytosolic E3 ligases, contributes to
efficient ubiquitylation. Red arrows indicate reactions
occurring in cells containing polyQ aggregates that
deplete Sis1p. See Discussion for details.Sis1p compared to Ydj1p (20,000 and 120,000 molecules per
cell, respectively; SGD, http://www.yeastgenome.org), coupled
with the limited capacity of the cytosolic proteasome system,
would ensure that misfolded proteins are selected for nuclear
degradation only after multiple attempts at refolding. Thus,
Sis1p performs a triage function conceptually similar to that of
the ER chaperone machinery in selecting substrates for ERAD.
Whether Sis1p interacts directly with nuclear importins remains
to be determined, but a specific role of Sis1p in nuclear transfer
is supported by several lines of evidence: CG* and Sis1p accu-
mulate in the nucleus after proteasome inhibition, triggering the
deposition of juxtanuclear CG* inclusions. Neither nuclear nor
cytosolic versions of Sis1p (NLS-Sis1p and NES-Sis1p) can
functionally replace wild-type Sis1p for protein degradation,
suggesting a model in which Sis1p shuttles between cytosol
and nucleus (Figure 7). Re-export of Sis1p to the cytosol is
apparently coupled with the transfer of misfolded protein to the
nuclear proteasome machinery, and this step is disrupted
when Sis1p carries a nuclear export signal.
We demonstrated that the nuclear pathway for the degrada-
tion of misfolded cytosolic proteins also exists in mammalian
cells, with DnaJB1 having a role similar to Sis1p. It will be impor-
tant to analyze this pathway inmore detail. For example, DnaJB1
may cooperate in protein clearance with the cytosolic E3 ligase
CHIP (Connell et al., 2001), not present in yeast, and with the
Hsp90 chaperone system (McClellan et al., 2005). Moreover,
mammalian cells contain multiple DnaJB proteins, which could
be specialized in mediating the degradation of misfolded pro-
teins with different structural properties.
EXPERIMENTAL PROCEDURES
Expression Constructs and Yeast Strains
Yeast manipulations and genetic experiments were carried out using standard
methods. A detailed description of yeast strains and expression constructs is
provided in Extended Experimental Procedures and Tables S2 and S3.Cell 154, 1Cycloheximide Chase Experiments
Cells were transferred from SC medium containing
2% glucose to SC medium containing 2% raffinose
and 2% galactose to induce the galactose-regulated
expression of reporter protein for 15–18 hr. Cyclohex-imide (0.5 mg/ml) was added and 2 OD600 of cells were removed at the indi-
cated time points. Total cell extracts were prepared by alkaline-lysis, ensuring
complete solubilization of the reporter protein analyzed, followed by immuno-
blotting with antibodies as indicated (Park et al., 2007).
Fluorescence Imaging
Fluorescence imaging of live yeast cells was performed using a Zeiss Axiovert
200M inverted fluorescence microscope and AxioVision 4.7.1 for image
analysis. Hoechst 33342 dye and DAPI were used for nuclear staining of live
and fixed cells, respectively. Confocal microscopy of HEK293 cells was
performed using the Leica TCS SP2 confocal laser scanning microscope
(Leica Microsystems) equipped with Acousto-Optical Beam Splitter (AOBS)
(see Extended Experimental Procedures).
SILAC Labeling and PolyQ-Interactor Analysis by LC-MS/MS
Yeast cells were grown over night in CM Ura-His-glucose medium containing
either 100 mg/l unlabeled (light) L-lysine (L) or 100 mg/l heavy L-lysine-13C6,
15N2 (H) (Ong and Mann, 2006). For the expression of galactose-inducible
proteins (CG* and polyQ proteins), labeled cells were grown in the same
medium but containing 2% raffinose and 2% galactose instead of glucose
for at least six generations until an OD600 of 0.8. Cell extracts were prepared
in lysis buffer (25 mM Tris-HCl [pH 7.5], 50 mM KCl, 10 mM MgCl2, 1 mM
EDTA, 5% glycerol, 0.5% Triton X-100, complete protease inhibitors [Roche])
and cleared by centrifugation (10min, 20,0003 g at 4C).Myc-tagged proteins
were isolated with anti-myc MicroBeads (Miltenyi Biotech) by incubation for
2 hr at 4C. After three washes with lysis buffer, bound proteins were eluted
with urea buffer (8 M urea, 5% SDS, 200 mM Tris-HCl [pH 6.8], 1 mM EDTA
0.1% bromophenol blue, 1.5% 2-mercaptoethanol) and (L) and (H)-eluates
mixed 1:1, followed by SDS-PAGE, in-gel digestion and LC-MS/MS analysis
(see Extended Experimental Procedures for details).
Mammalian Cell Culture
Human HEK293 cells were cultured under standard conditions (Gupta et al.,
2011) (see Extended Experimental Procedures). Transient transfections were
performed with FuGene 6 according to the manufacturer’s protocol.
Miscellaneous
Filter-trap assays to detect polyQ aggregates, immunoprecipitation ex-
periments, and the isolation of His6-Ub conjugated proteins were performed
as described in Extended Experimental Procedures). Immunoblots were34–145, July 3, 2013 ª2013 Elsevier Inc. 143
developed using the chemiluminescence kit Rodeo ECL (USB) and analyzed
using a LAS-3000 image reader (Fujifilm) and the AIDA software (Raytest).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2013.06.003.
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